As of 2025-07-03, the Relative Valuation of Clinuvel Pharmaceuticals Ltd (CUV.AX) is 14.28 AUD. This relative valuation is based on P/E multiples. With the latest stock price at 9.99 AUD, the upside of Clinuvel Pharmaceuticals Ltd based on Relative Valuation is 43.0%.
The range of the Relative Valuation is 7.98 - 22.30 AUD.
| Range | Selected | |
| Trailing P/E multiples | 10.3x - 11.2x | 10.8x |
| Forward P/E multiples | 26.0x - 31.9x | 29.0x |
| Fair Price | 7.98 - 22.30 | 14.28 |
| Upside | -20.1% - 123.2% | 43.0% |
| Date | P/E |
| 2025-06-27 | 13.51 |
| 2025-06-26 | 13.21 |
| 2025-06-25 | 13.13 |
| 2025-06-24 | 12.99 |
| 2025-06-23 | 12.23 |
| 2025-06-20 | 12.56 |
| 2025-06-19 | 12.65 |
| 2025-06-18 | 12.50 |
| 2025-06-17 | 12.67 |
| 2025-06-16 | 12.71 |
| 2025-06-13 | 12.72 |
| 2025-06-12 | 13.16 |
| 2025-06-11 | 13.34 |
| 2025-06-10 | 13.49 |
| 2025-06-06 | 13.33 |
| 2025-06-05 | 13.34 |
| 2025-06-04 | 13.64 |
| 2025-06-03 | 12.82 |
| 2025-06-02 | 13.39 |
| 2025-05-30 | 13.99 |
| 2025-05-29 | 14.17 |
| 2025-05-28 | 14.18 |
| 2025-05-27 | 13.68 |
| 2025-05-26 | 13.57 |
| 2025-05-23 | 13.75 |
| 2025-05-22 | 13.58 |
| 2025-05-21 | 13.64 |
| 2025-05-20 | 13.95 |
| 2025-05-19 | 13.71 |
| 2025-05-16 | 13.90 |
| 2025-05-15 | 14.01 |
| 2025-05-14 | 13.99 |
| 2025-05-13 | 14.37 |
| 2025-05-12 | 14.24 |
| 2025-05-09 | 14.57 |
| 2025-05-08 | 14.57 |
| 2025-05-07 | 14.67 |
| 2025-05-06 | 14.67 |
| 2025-05-05 | 14.71 |
| 2025-05-02 | 14.97 |
| 2025-05-01 | 15.05 |
| 2025-04-30 | 14.61 |
| 2025-04-29 | 14.65 |
| 2025-04-28 | 14.04 |
| 2025-04-24 | 14.21 |
| 2025-04-23 | 14.27 |
| 2025-04-22 | 13.65 |
| 2025-04-17 | 14.00 |
| 2025-04-16 | 13.83 |
| 2025-04-15 | 13.92 |